MCE - Delayed Quote EUR

Clínica Baviera, S.A. (CBAV.MC)

28.10 -0.30 (-1.06%)
At close: 5:29 PM GMT+2

Key Executives

Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Eduardo Baviera Sabater CEO & Executive Director 200k -- 1968
Mr. Julio Baviera Sabater President 43.33k -- 1955
Mr. Virgilio Leal Espí Chief Financial Officer -- -- --
Mr. Antonio Peral Ortiz de la Torre Company Secretary -- -- --

Clínica Baviera, S.A.

Paseo de la Castellana 20
Madrid
Spain
34 917 82 03 60 https://www.clinicabaviera.com
Sector: 
Healthcare
Full Time Employees: 
1,254

Description

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments. The company is based in Madrid, Spain.

Corporate Governance

Clínica Baviera, S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • May 31, 2023
    Ex-Dividend Date

Upcoming Events

Jun 07, 2024 - Jun 11, 2024
Clínica Baviera, S.A. Earnings Call

Related Tickers

PRPH ProPhase Labs, Inc.
4.8400
-2.21%
 
MTD Mettler-Toledo International Inc.
1,247.60
+1.19%
 
CRL Charles River Laboratories International, Inc.
228.78
+0.43%
 
VNRX VolitionRx Limited
0.9000
+1.11%
 
MEDP Medpace Holdings, Inc.
390.15
+0.10%
 
DHR Danaher Corporation
247.05
+0.51%
 
TMO Thermo Fisher Scientific Inc.
573.01
+0.22%